TCT 525: Cutting Balloon versus Standard Balloon for Lesion Preparation of Drug-Coated Balloon Treatment in De-novo Coronary Artery Lesions: Primary Endpoint of the Randomized NATURE Trial

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Boston Scientific Corporation; Medtronic; Shockwave Medical</li><li>Grant Support/Research Contract - Abbott</li></ul>